These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26599114)

  • 1. Bone Remodeling Under Pathological Conditions.
    Xiao W; Li S; Pacios S; Wang Y; Graves DT
    Front Oral Biol; 2016; 18():17-27. PubMed ID: 26599114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis.
    Lerner UH
    J Dent Res; 2006 Jul; 85(7):596-607. PubMed ID: 16798858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone cell interactions and regulation by inflammatory mediators.
    Oates TW; Cochran DL
    Curr Opin Periodontol; 1996; 3():34-44. PubMed ID: 8624568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and Molecular Aspects of Bone Remodeling.
    Xiao W; Wang Y; Pacios S; Li S; Graves DT
    Front Oral Biol; 2016; 18():9-16. PubMed ID: 26599113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.
    Kearns AE; Khosla S; Kostenuik PJ
    Endocr Rev; 2008 Apr; 29(2):155-92. PubMed ID: 18057140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress and perspectives in bone research].
    Matsumoto T
    Nihon Rinsho; 2011 Jul; 69(7):1175-80. PubMed ID: 21774354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [How is bone remodeling regulated?].
    Takeuchi Y
    Nihon Rinsho; 2009 May; 67(5):897-902. PubMed ID: 19432106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of microgravity on bone metabolism in vitro and in vivo.
    Loomer PM
    Crit Rev Oral Biol Med; 2001; 12(3):252-61. PubMed ID: 11497376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple Myeloma and Bone: The Fatal Interaction.
    Marino S; Roodman GD
    Cold Spring Harb Perspect Med; 2018 Aug; 8(8):. PubMed ID: 29229668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of prostaglandins in bone in vivo.
    Norrdin RW; Jee WS; High WB
    Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):139-49. PubMed ID: 2281118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone turnover markers in the management of postmenopausal osteoporosis.
    Brown JP; Albert C; Nassar BA; Adachi JD; Cole D; Davison KS; Dooley KC; Don-Wauchope A; Douville P; Hanley DA; Jamal SA; Josse R; Kaiser S; Krahn J; Krause R; Kremer R; Lepage R; Letendre E; Morin S; Ooi DS; Papaioaonnou A; Ste-Marie LG
    Clin Biochem; 2009 Jul; 42(10-11):929-42. PubMed ID: 19362543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the Balance Between Total Bone Formation and Total Bone Resorption: An Index of Net Bone Formation.
    Shieh A; Han W; Ishii S; Greendale GA; Crandall CJ; Karlamangla AS
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2802-9. PubMed ID: 27336357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoclastogenesis and Osteogenesis during Tooth Movement.
    Baloul SS
    Front Oral Biol; 2016; 18():75-9. PubMed ID: 26599120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actions of osteoporosis treatments on bone histomorphometric remodeling: a two-fold principal component analysis.
    Wan X; Zhao Y; Burge R; Jiang Y
    Osteoporos Int; 2013 Dec; 24(12):3011-9. PubMed ID: 23881284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The cytokines that maintain living bone].
    Riancho JA; Zarrabeitia MT; González Macías J
    Med Clin (Barc); 1992 Jun; 99(3):110-5. PubMed ID: 1630198
    [No Abstract]   [Full Text] [Related]  

  • 16. Are nonresorbing osteoclasts sources of bone anabolic activity?
    Karsdal MA; Martin TJ; Bollerslev J; Christiansen C; Henriksen K
    J Bone Miner Res; 2007 Apr; 22(4):487-94. PubMed ID: 17227224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of RANKL in bone diseases.
    Anandarajah AP
    Trends Endocrinol Metab; 2009 Mar; 20(2):88-94. PubMed ID: 19185505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of bone loss in disuse osteoporosis.
    Alexandre C; Vico L
    Joint Bone Spine; 2011 Dec; 78(6):572-6. PubMed ID: 21664854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
    Seeman E
    Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption.
    Kitaura H; Marahleh A; Ohori F; Noguchi T; Shen WR; Qi J; Nara Y; Pramusita A; Kinjo R; Mizoguchi I
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.